NEW YORK (GenomeWeb News) – PerkinElmer reduced its workforce by 62 employees during the first quarter as part of a restructuring plan, the company said in its Form 10-Q filed with the US Securities and Exchange Commission on Monday.

The restructuring plan, approved during the first quarter, focuses resources on higher growth end markets and resulted in a $2.3 million pre-tax restructuring charge PerkinElmer took in its Human Health segment related to the workforce reduction, and a $200,000 pre-tax restructuring charge it took in its Environmental Health segment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.